New York jury holds drug firm Teva liable in opioid crisis
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - ABC17NEWS
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Pfizer gets $2.15 billion settlement
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
The Unlikely Source of a Healthtech Revolution - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva's job-cut tally could touch 10K: report | FiercePharma
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case | Time
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva Wins Appeal That Upholds Three Patents for Migraine Drug
Opioid crisis: 4 pharmaceutical companies accused in the opioid epidemic reach a $260 million settlement just before trial | CNN
The Difficulties of Cloning a CEO - Bloomberg
Teva is on the prowl and its investors are taking notice
Generic Makers to Challenge Ruling Upholding Teva Cancer Drug
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - BNN Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On
Israel's Teva Buys Allergan's Generics Business For $40 Billion | Fortune
